Paris

Litigation, Arbitration and Settlements in the Pharma Sector

The “Litigation, Arbitration and Settlements in the Pharma Sector” workshop organised by Concurrences in partnership with Fréget Glaser & Associés and NERA Economic Consulting took place in Paris on November 30th, 2022.

– Photos: See below
– Video: Available for Concurrences+ subscribers (to be published below soon)
– Audio: Available for Concurrences+ subscribers (to be published below soon)
– Synthesis: Available for Concurrences+ subscribers (See above)
– Transcript: Available for Concurrences+ subscribers (See above)
– Concurrences Related Articles (Click Read More below and see page’s bottom)

Check the Upcoming Events section for the next events.

SYNTHESIS

Alexandre Carbonnel

Several recent cases have concerned practices that may weaken or eliminate the competitive constraint exercised by generics on originators. We can make a distinction between unilateral practices such as the disparagement of generics, which may arise when originators communicate misleading information on generics to prescribers in order to limit the penetration of generics in the market, and concerted practices such as ‘pay-for-delay’ agreements.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

Speakers